Interim Analyses: An FDA Reviewer's Experience and Perspective
- 1 April 1995
- journal article
- review article
- Published by Springer Nature in Drug Information Journal
- Vol. 29 (2) , 729-737
- https://doi.org/10.1177/009286159502900252
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The Use of Interim Analysis for Sample Size AdjustmentDrug Information Journal, 1993
- Interim analysis in the pharmaceutical industryControlled Clinical Trials, 1993
- When to stop a clinical trial.BMJ, 1992
- Practical problems in interim analyses, with particular regard to estimationControlled Clinical Trials, 1989
- Designs for group sequential testsControlled Clinical Trials, 1984
- Discrete sequential boundaries for clinical trialsBiometrika, 1983
- Stochastically curtailed tests in long–term clinical trialsCommunications in Statistics. Part C: Sequential Analysis, 1982
- Group sequential methods in the design and analysis of clinical trialsBiometrika, 1977
- Repeated Significance Tests on Accumulating DataJournal of the Royal Statistical Society. Series A (General), 1969